RecruitingPhase 1NCT03460977
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
Sponsor: Pfizer
Boston, MA · Newton, MA · +42 more sites
2 recruiting prostate cancer studies with a site in Newton, MA.
Sponsor: Pfizer
Boston, MA · Newton, MA · +42 more sites
Sponsor: Daiichi Sankyo
Boston, MA · Newton, MA · +7 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.